Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Complementary Medicines
Database
Language
Affiliation country
Publication year range
1.
Neurosci Lett ; 564: 94-8, 2014 Apr 03.
Article in English | MEDLINE | ID: mdl-24560952

ABSTRACT

In prior studies, systemic opioid receptor antagonism with naltrexone (NTX) failed to block flavor preference conditioning by the sweet taste or post-oral actions of sugar despite reducing overall flavored saccharin intake. Further, NTX microinjections into the nucleus accumbens (NAc) shell or core failed to alter the expression of preferences conditioned by the sweet taste or post-oral actions of sugars. In contrast, fructose-conditioned flavor preferences (CFP) were reduced or eliminated by systemic or intracerebral administration of dopamine (DA) D1 or D2 antagonists in the NAc, medial prefrontal cortex (mPFC), amygdala (AMY) or lateral hypothalamus (LH). The present study examined whether NTX microinjections into the mPFC, AMY or LH would alter expression of fructose-CFP and total flavored saccharin intake. Food-restricted rats with bilateral cannulae aimed at the mPFC, AMY or LH were trained to drink a fructose (8%)+saccharin (0.2%) solution mixed with one flavor (CS+, e.g., cherry) and a 0.2% saccharin solution mixed with another flavor (CS-, e.g., grape) during 10 one-bottle sessions. Two-bottle tests with the cherry and grape flavors in 0.2% saccharin solutions occurred 10min following total bilateral NTX doses of 0, 1, 25 and 50µg administered into the mPFC, AMY or LH. Rats preferred the CS+ over CS- flavor following vehicle and all NTX doses administered into either the mPFC or LH. CS+ intake was significantly greater than CS- intake following vehicle and the low NTX dose in the AMY; however, at the 25 and 50µg AMY NTX doses, CS+ intakes did not significantly exceed CS- intakes. Total flavored saccharin intake was significantly reduced by all three LH NTX doses (20-35%), by the 25 (14%) and 50 (22%)µg AMY NTX doses, but not by mPFC NTX. Thus, opioid antagonism in the AMY, but not the mPFC or LH attenuated, but did not block the expression of fructose-CFP, and LH and AMY, but not mPFC, NTX significantly reduced total saccharin intake. Therefore, whereas opioid antagonism in the LH and AMY reduces sweet intake, they appear less effective in altering fructose-CFP.


Subject(s)
Amygdala/physiology , Food Preferences/physiology , Fructose/administration & dosage , Hypothalamus/physiology , Narcotic Antagonists/pharmacology , Prefrontal Cortex/physiology , Saccharin/administration & dosage , Amygdala/drug effects , Animals , Conditioning, Psychological , Drinking Behavior , Food Preferences/drug effects , Hypothalamus/drug effects , Male , Naltrexone/pharmacology , Prefrontal Cortex/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Opioid
SELECTION OF CITATIONS
SEARCH DETAIL